Clinical Trial Update: Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients

View source ↗

Summary

This clinical trial investigates pharmacogenomic factors influencing mood disorders in patients with chronic kidney disease and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Major Depressive Disorder

Snippet

Sponsor: Wonju Severance Christian Hospital | Conditions: Chronic Kidney Disease(CKD), Depression | Status: NOT_YET_RECRUITING